Follow
David H Lovett MD
David H Lovett MD
University of Califiornia San Francisco Department of Medicine/Nephrology
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation
S Cheng, DH Lovett
The American journal of pathology 162 (6), 1937-1949, 2003
3432003
Structure and expression of the human gene for the matrix metalloproteinase matrilysin.
M Gaire, Z Magbanua, S McDonnell, L McNeil, DH Lovett, LM Matrisian
Journal of Biological Chemistry 269 (3), 2032-2040, 1994
2981994
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury
S Cheng, AS Pollock, R Mahimkar, JL Olson, DH Lovett, S Cheng, ...
The FASEB journal 20 (11), 1898-1900, 2006
2892006
Stimulation of rat mesangial cell proliferation by macrophage interleukin 1.
DH Lovett, JL Ryan, RB Sterzel
Journal of immunology (Baltimore, Md.: 1950) 131 (6), 2830-2836, 1983
2861983
Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix …
E Olaso, JP Labrador, LH Wang, K Ikeda, FJ Eng, R Klein, DH Lovett, ...
Journal of biological chemistry 277 (5), 3606-3613, 2002
2732002
Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney.
LK Lee, TW Meyer, AS Pollock, DH Lovett
The Journal of clinical investigation 96 (2), 953-964, 1995
2631995
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB …
MR Bergman, S Cheng, N Honbo, L Piacentini, JS Karliner, DH Lovett
Biochemical Journal 369 (3), 485-496, 2003
2392003
Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction
MR Bergman, JR Teerlink, R Mahimkar, L Li, BQ Zhu, A Nguyen, S Dahi, ...
American journal of physiology-heart and circulatory physiology 292 (4 …, 2007
2312007
Proteinases and glomerular matrix turnover
M Davies, J Martin, GJ Thomas, DH Lovett
Kidney international 41 (3), 671-678, 1992
2301992
The 31-kDa precursor of interleukin 1 alpha is myristoylated on specific lysines within the 16-kDa N-terminal propiece.
FT Stevenson, SL Bursten, C Fanton, RM Locksley, DH Lovett
Proceedings of the National Academy of Sciences 90 (15), 7245-7249, 1993
2201993
Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1
PR Mertens, S Harendza, AS Pollock, DH Lovett
Journal of Biological Chemistry 272 (36), 22905-22912, 1997
2151997
Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis.
D Lovett, B Kozan, M Hadam, K Resch, D Gemsa
Journal of immunology (Baltimore, Md.: 1950) 136 (1), 340-347, 1986
2091986
The N-terminal propiece of interleukin 1α is a transforming nuclear oncoprotein
FT Stevenson, J Turck, RM Locksley, DH Lovett
Proceedings of the National Academy of Sciences 94 (2), 508-513, 1997
2071997
Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.
JI McMillan, JW Riordan, WG Couser, AS Pollock, DH Lovett
The Journal of clinical investigation 97 (4), 1094-1101, 1996
2031996
Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation
J Turck, AS Pollock, LK Lee, HP Marti, DH Lovett
Journal of Biological Chemistry 271 (25), 15074-15083, 1996
1931996
Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor.
DH Lovett, M Szamel, JL Ryan, RB Sterzel, D Gemsa, K Resch
Journal of immunology (Baltimore, Md.: 1950) 136 (10), 3700-3705, 1986
1931986
Neutral proteinase activity produced in vitro by cells of the glomerular mesangium
DH Lovett, RB Sterzel, M Kashgarian, JL Ryan
Kidney International 23 (2), 342-349, 1983
1801983
Activation of glomerular mesangial cells by the terminal membrane attack complex of complement.
DH Lovett, GM Haensch, M Goppelt, K Resch, D Gemsa
Journal of immunology (Baltimore, Md.: 1950) 138 (8), 2473-2480, 1987
1671987
Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen
K Ikeda, LH Wang, R Torres, H Zhao, E Olaso, FJ Eng, P Labrador, ...
Journal of biological chemistry 277 (21), 19206-19212, 2002
1632002
A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription
PR Mertens, MA Alfonso-Jaume, K Steinmann, DH Lovett
Journal of Biological Chemistry 273 (49), 32957-32965, 1998
1561998
The system can't perform the operation now. Try again later.
Articles 1–20